USFDA
-
September 28, 2020, Monday
As domestic sales decline, drug makers focus on exports to sustain growth
During April-July, drug makers exported products worth $ 7.4 billion, a growth of 9.5 per cent on year on year basis
-
September 25, 2020, Friday
Cipla gets final approval from USFDA for multiple sclerosis drug
Drug major Cipla on Friday said it has received final approval from the US health regulator for Dimethyl Fumarate capsules, ...
-
September 25, 2020, Friday
Zydus Cadila gets USFDA nod for multiple sclerosis treatment drug
Zydus Cadila said it received approval from the USFDA to market Dimethyl Fumarate delayed release capsules, indicated for the ...
-
September 24, 2020, Thursday
Zydus Cadila gets tentative USFDA approval to market anti-cancer drug
Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer ...
-
September 20, 2020, Sunday
ICMR exploring saliva-based tests to diagnose Covid-19: Harsh Vardhan
Vardhan also said that no significant or drastic mutations had been found in strains of SARS-CoV-2 in India till now
-
September 18, 2020, Friday
Zydus Cadila gets USFDA nod to market mineral supplement tablets
Zydus Cadila said it has received approval from USFDA to market potassium chloride extended release tablets, a mineral supplement ...
-
September 18, 2020, Friday
Emergency use authorisation of drugs or vaccines: What, when, how
The US Food and Drug Administration had recently allowed the emergency use of convalescent plasma therapy for Covid treatment, ...
-
September 16, 2020, Wednesday
USFDA's Hahn plans significant work with AstraZeneca in Covid trial inquiry
The top US Food and Drug Administration official confirmed AstraZeneca's US Covid-19 vaccine trial is on hold
-
September 14, 2020, Monday
Indoco Remedies gets USFDA nod for blood thinning drug Apixaban tablets
Drug firm Indoco Remedies said it has received approval from the US health regulator for blood thinning drug Apixaban tablets
-
September 14, 2020, Monday
Donald Trump signs new, expanded executive order to lower US drug prices
Donald Trump signed a new executive order on Sunday aimed at lowering drug prices in the United States by linking them to those ...
